These rates were high compared with human melanoma, squamous cell carcinoma, and urothelial cancer, in which 51–71% was PD-L1-positive and only 14–31% was TPS ≥ 50%31, suggesting the differences in etiology or immune microenvironment of cancers between dogs and humans. This evidence concerns the gene CD274 and melanoma.